4166 logo

Orient Pharma Co., Ltd. Stock Price

TPEX:4166 Community·NT$6.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

4166 Share Price Performance

NT$0
-36.10 (-100.00%)
NT$0
-36.10 (-100.00%)
Price NT$0

4166 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with proven track record.

0 Risks
2 Rewards

Orient Pharma Co., Ltd. Key Details

NT$1.3b

Revenue

NT$577.6m

Cost of Revenue

NT$700.2m

Gross Profit

NT$572.2m

Other Expenses

NT$128.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.53
54.80%
10.02%
0%
View Full Analysis

About 4166

Founded
2008
Employees
n/a
CEO
Chun-Tong Huang
WebsiteView website
www.oppharma.com

Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson’s and Alzheimer’s diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.

Recent 4166 News & Updates

Recent updates

No updates